{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:33:22Z","timestamp":1791772402146,"version":"4.3.4"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/spc.0000000000000017","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T17:11:23Z","timestamp":1382548283000},"page":"361-367","source":"Crossref","is-referenced-by-count":93,"title":["Gut barrier dysfunction and microbial translocation in cancer cachexia"],"prefix":"10.1097","volume":"7","author":[{"given":"Gerald L.","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryon W.","family":"Petschow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey L.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20211004","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition.","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"R2-6-20211004","doi-asserted-by":"crossref","first-page":"601434","DOI":"10.1155\/2011\/601434","article-title":"Cancer cachexia: mechanisms and clinical implications.","volume":"2011","author":"Donohoe","year":"2011","journal-title":"Gastroenterol Res Practice"},{"key":"R3-6-20211004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/SPC.0b013e3282f4b734","article-title":"Weight loss in patients with advanced cancer: effects, causes, and potential management.","volume":"2","author":"Jatoi","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"R4-6-20211004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13539-012-0075-5","article-title":"Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers, Journal of cachexia, sarcopenia and muscle.","volume":"3","author":"Utech","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R5-6-20211004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13539-013-0105-y","article-title":"Cachexia as a major public health problem: frequent, costly, and deadly.","volume":"4","author":"Farkas","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R6-6-20211004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia.","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"R7-6-20211004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/cmi.2010.67","article-title":"The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.","volume":"8","author":"Tlaskalova-Hogenova","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"R8-6-20211004","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","article-title":"Gut barrier dysfunction in the Apc(Min) mouse model of colon cancer cachexia.","volume":"1812","author":"Puppa","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R9-6-20211004","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.mco.0000134363.53782.cb","article-title":"Cancer anorexia-cachexia syndrome: cytokines and neuropeptides.","volume":"7","author":"Ramos","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R10-6-20211004","doi-asserted-by":"crossref","first-page":"R674","DOI":"10.1152\/ajpregu.00104.2006","article-title":"IGF-1 is downregulated in experimental cancer cachexia.","volume":"291","author":"Costelli","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R11-6-20211004","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mco.0000165004.93707.88","article-title":"Systemic inflammation, cachexia and prognosis in patients with cancer.","volume":"8","author":"Deans","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R12-6-20211004","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1373\/clinchem.2007.091959","article-title":"C-reactive protein and all-cause mortality in a large hospital-based cohort.","volume":"54","author":"Marsik","year":"2008","journal-title":"Clin Chem"},{"key":"R13-6-20211004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6604828","article-title":"The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer.","volume":"100","author":"Deans","year":"2009","journal-title":"Br J Cancer"},{"key":"R14-6-20211004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pharmthera.2006.11.004","article-title":"Therapeutic approaches for muscle wasting disorders.","volume":"113","author":"Lynch","year":"2007","journal-title":"Pharmacol Ther"},{"key":"R15-6-20211004","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","article-title":"Cancer cachexiapathophysiology and management.","volume":"48","author":"Suzuki","year":"2013","journal-title":"J Gastroenterol"},{"key":"R16-6-20211004","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-012-0087-1","article-title":"Cancer cachexia: impact, mechanisms and emerging treatments.","volume":"4","author":"Vaughan","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R17-6-20211004","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13539-013-0111-0","article-title":"Why cachexia kills: examining the causality of poor outcomes in wasting conditions.","volume":"4","author":"Kalantar-Zadeh","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R18-6-20211004","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1357-2725(02)00251-0","article-title":"Cancer cachexia: the molecular mechanisms.","volume":"35","author":"Argiles","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"R19-6-20211004","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1207\/S15327914NC352_5","article-title":"Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer.","volume":"35","author":"OGorman","year":"1999","journal-title":"Nutr Cancer"},{"key":"R20-6-20211004","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/PL00012351","article-title":"Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia.","volume":"23","author":"Fearon","year":"1999","journal-title":"World J Surg"},{"key":"R21-6-20211004","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1200\/JCO.1995.13.10.2600","article-title":"Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.","volume":"13","author":"Staal-van den Brekel","year":"1995","journal-title":"J Clin Oncol"},{"key":"R22-6-20211004","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9","article-title":"Acute-phase protein response and survival duration of patients with pancreatic cancer.","volume":"75","author":"Falconer","year":"1995","journal-title":"Cancer"},{"key":"R23-6-20211004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/SPC.0b013e3283311d09","article-title":"The role of cytokines in cancer cachexia.","volume":"3","author":"Argiles","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"key":"R24-6-20211004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1072-7515(03)00382-X","article-title":"Understanding and managing cancer cachexia.","volume":"197","author":"MacDonald","year":"2003","journal-title":"J Am Coll Surg"},{"key":"R25-6-20211004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000079408","article-title":"A cytokine-based neuroimmunologic mechanism of cancer-related symptoms.","volume":"11","author":"Lee","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"R26-6-20211004","first-page":"4653","article-title":"Targeted antiinterleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.","volume":"9","author":"Trikha","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R27-6-20211004","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/bjc.1997.433","article-title":"Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients.","volume":"76","author":"Cariuk","year":"1997","journal-title":"Br J Cancer"},{"key":"R28-6-20211004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","article-title":"The role of myostatin in muscle wasting: an overview.","volume":"2","author":"Elkina","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R29-6-20211004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","article-title":"Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications.","volume":"69","author":"Natividad","year":"2013","journal-title":"Pharmacol Res"},{"key":"R30-6-20211004","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.2741\/3413","article-title":"Mechanism of cytokine modulation of epithelial tight junction barrier.","volume":"14","author":"Al-Sadi","year":"2009","journal-title":"Front Biosci"},{"key":"R32-6-20211004","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1440-1746.2003.03032.x","article-title":"Intestinal barrier: an interface between health and disease.","volume":"18","author":"Farhadi","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"R33-6-20211004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-immunol-020711-075001","article-title":"Microbial translocation across the GI tract.","volume":"30","author":"Brenchley","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"R34-6-20211004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00004836-200204000-00003","article-title":"Intestinal permeation and gastrointestinal disease.","volume":"34","author":"DeMeo","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R35-6-20211004","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbamem.2008.10.028","article-title":"Tight junctions as targets of infectious agents.","volume":"1788","author":"Guttman","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"R36-6-20211004","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/SPC.0b013e32835f3e8c","article-title":"Chemotherapy-induced mucosal barrier dysfunction: an updated review on the role of intestinal tight junctions.","volume":"7","author":"Wardill","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"R38-6-20211004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/153537020623100202","article-title":"Gastrointestinal inflammation: a central component of mucosal defense and repair.","volume":"231","author":"Martin","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"R39-6-20211004","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJMra1207068","article-title":"Peripheral mechanisms in irritable bowel syndrome.","volume":"367","author":"Camilleri","year":"2012","journal-title":"N Engl J Med"},{"key":"R40-6-20211004","doi-asserted-by":"crossref","first-page":"G775","DOI":"10.1152\/ajpgi.00155.2012","article-title":"Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.","volume":"303","author":"Camilleri","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R41-6-20211004","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/labinvest.3700316","article-title":"Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells.","volume":"85","author":"Prasad","year":"2005","journal-title":"Lab Invest"},{"key":"R42-6-20211004","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/MCB.06029-11","article-title":"Occludin: one protein, many forms.","volume":"32","author":"Cummins","year":"2012","journal-title":"Mol Cell Biol"},{"key":"R43-6-20211004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fimmu.2012.00107","article-title":"Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer.","volume":"3","author":"Rubin","year":"2012","journal-title":"Front Immunol"},{"key":"R44-6-20211004","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/carcin\/bgs006","article-title":"Inflammation DNA methylation and colitis-associated cancer.","volume":"33","author":"Hartnett","year":"2012","journal-title":"Carcinogenesis"},{"key":"R45-6-20211004","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.critrevonc.2008.07.021","article-title":"Infections and cancer: established associations and new hypotheses.","volume":"70","author":"de Martel","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"R46-6-20211004","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis.","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"R47-6-20211004","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2741\/1816","article-title":"Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review.","volume":"11","author":"Deitch","year":"2006","journal-title":"Front Biosci"},{"key":"R48-6-20211004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccc.2005.01.005","article-title":"Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level.","volume":"21","author":"Fink","year":"2005","journal-title":"Crit Care Clin"},{"key":"R49-6-20211004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7243\/2049-7962-1-19","article-title":"Detection of bacterial DNA in serum from colon cancer patients: association with cytokine levels and cachexia.","volume":"1","author":"Zhang","year":"2012","journal-title":"Cancer Ther Res"},{"key":"R50-6-20211004","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine.","volume":"307","author":"Backhed","year":"2005","journal-title":"Science"},{"key":"R51-6-20211004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.gastro.2011.04.011","article-title":"Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis.","volume":"141","author":"Lepage","year":"2011","journal-title":"Gastroenterology"},{"key":"R52-6-20211004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ibd.21339","article-title":"Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.","volume":"17","author":"Frank","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R53-6-20211004","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity.","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"R54-6-20211004","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R55-6-20211004","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R56-6-20211004","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/ibd.20903","article-title":"Low counts of Faecalibacterium prausnitzii in colitis microbiota.","volume":"15","author":"Sokol","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R57-6-20211004","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.2337\/db10-0253","article-title":"Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.","volume":"59","author":"Furet","year":"2010","journal-title":"Diabetes"},{"key":"R58-6-20211004","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1053\/j.gastro.2011.07.043","article-title":"Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.","volume":"141","author":"Rajilic-Stojanovic","year":"2011","journal-title":"Gastroenterology"},{"key":"R59-6-20211004","first-page":"5","article-title":"Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review.","volume":"28","author":"Elia","year":"2006","journal-title":"Int J Oncol"},{"key":"R60-6-20211004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2005.07.026","article-title":"Prevention and treatment of cancer cachexia: new insights into an old problem.","volume":"42","author":"Muscaritoli","year":"2006","journal-title":"Eur J Cancer"},{"key":"R61-6-20211004","first-page":"CD004597","article-title":"Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia.","volume":"1","author":"Dewey","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R62-6-20211004","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-011-0028-4","article-title":"Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise.","volume":"2","author":"Penna","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R63-6-20211004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5713\/ajas.2010.70630","article-title":"Spray dried animal plasma as an alternative to antibiotics in weanling pigs - A review.","volume":"23","author":"Torrallardona","year":"2010","journal-title":"Asian-Aust J Anim Sci"},{"key":"R64-6-20211004","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/QAD.0b013e328362e54c","article-title":"Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy.","volume":"27","author":"Asmuth","year":"2013","journal-title":"AIDS"},{"key":"R65-6-20211004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005176-199710000-00003","article-title":"Acceptability, safety, and digestibility of spray-dried bovine serum added to diets of recovering malnourished children.","volume":"25","author":"Lembcke","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R66-6-20211004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MOG.0b013e328341373e","article-title":"Progress in the field of probiotics: year.","volume":"27","author":"Deshpande","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"R67-6-20211004","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.ajpath.2013.01.013","article-title":"Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis.","volume":"182","author":"Bergmann","year":"2013","journal-title":"Am J Pathol"},{"key":"R68-6-20211004","doi-asserted-by":"crossref","first-page":"G851","DOI":"10.1152\/ajpgi.00327.2009","article-title":"Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier.","volume":"298","author":"Karczewski","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R69-6-20211004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1753-4887.2008.00141.x","article-title":"Cross-talk of human gut with bifidobacteria.","volume":"67","author":"Trebichavsky","year":"2009","journal-title":"Nutr Rev"},{"key":"R70-6-20211004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijmm.2009.08.006","article-title":"Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.","volume":"300","author":"Hormannsperger","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"R71-6-20211004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jped.2013.02.004","article-title":"Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis.","volume":"89","author":"Bernardo","year":"2013","journal-title":"J Pediatr (Rio J)"},{"key":"R72-6-20211004","first-page":"CD006095","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.","volume":"5","author":"Goldenberg","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R73-6-20211004","first-page":"CD006895","article-title":"Probiotics for preventing acute upper respiratory tract infections.","volume":"9","author":"Hao","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R74-6-20211004","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.gtc.2012.08.007","article-title":"Probiotics in the development and treatment of allergic disease.","volume":"41","author":"Isolauri","year":"2012","journal-title":"Gastroenterol Clin North Am"},{"key":"R75-6-20211004","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","article-title":"VSL3 probiotic-mixture induces remission in patients with active ulcerative colitis.","volume":"100","author":"Bibiloni","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R77-6-20211004","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1365-2036.2006.02927.x","article-title":"Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.","volume":"23","author":"Zocco","year":"2006","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201312000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T08:34:00Z","timestamp":1633509240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201312000-00006"}},"subtitle":["a new therapeutic target"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000017","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}